Stephens Investment Management Group LLC lowered its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 7.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 714,660 shares of the company’s stock after selling 58,951 shares during the quarter. Medidata Solutions comprises 1.2% of Stephens Investment Management Group LLC’s portfolio, making the stock its 15th biggest holding. Stephens Investment Management Group LLC owned 1.14% of Medidata Solutions worth $64,684,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Quadrant Capital Group LLC raised its stake in shares of Medidata Solutions by 126.8% in the first quarter. Quadrant Capital Group LLC now owns 592 shares of the company’s stock worth $40,000 after buying an additional 331 shares during the period. Flagship Harbor Advisors LLC raised its stake in shares of Medidata Solutions by 58.3% in the second quarter. Flagship Harbor Advisors LLC now owns 475 shares of the company’s stock worth $42,000 after buying an additional 175 shares during the period. World Asset Management Inc bought a new position in shares of Medidata Solutions in the first quarter worth about $210,000. Janney Montgomery Scott LLC bought a new position in shares of Medidata Solutions in the second quarter worth about $214,000. Finally, BBT Capital Management LLC bought a new position in shares of Medidata Solutions in the first quarter worth about $226,000. 96.04% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Robert Taylor sold 3,294 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $90.88, for a total transaction of $299,358.72. Following the completion of the sale, the director now directly owns 41,757 shares of the company’s stock, valued at approximately $3,794,876.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.70% of the stock is currently owned by company insiders.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Monday, July 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.17 by $0.31. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The firm had revenue of $180.50 million during the quarter, compared to analyst estimates of $179.95 million. During the same period last year, the company earned $0.43 EPS. Medidata Solutions’s quarterly revenue was up 15.8% compared to the same quarter last year. Equities analysts predict that Medidata Solutions Inc will post 0.8 EPS for the current year.
Several research analysts have recently commented on the company. Guggenheim downgraded Medidata Solutions from a “buy” rating to a “neutral” rating and set a $92.25 price objective on the stock. in a research note on Wednesday, June 12th. Wells Fargo & Co reissued a “hold” rating on shares of Medidata Solutions in a research note on Thursday, June 13th. Dougherty & Co downgraded Medidata Solutions from a “buy” rating to a “neutral” rating in a research note on Wednesday, May 1st. JPMorgan Chase & Co. raised Medidata Solutions from an “underweight” rating to a “neutral” rating in a research note on Wednesday, June 12th. Finally, SunTrust Banks lifted their target price on Medidata Solutions from $85.00 to $92.25 and gave the company a “hold” rating in a research note on Thursday, June 13th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $84.27.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Further Reading: What is a Roth IRA?
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.